Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study

Journal Title: Medpulse International Journal of Pharmacology - Year 2019, Vol 10, Issue 2

Abstract

Background:Metformin and Vildagliptin have independent glucose-lowering properties and may increase GLP-1 levels by working through complementary mechanisms. The combination of metformin and glimepiride is a well-established therapy for type 2 DM.Aim: To compare the efficacy and safety of vildagliptin-metformin and glimepiride-metformin treatment in type 2 diabetic patients.Material and Methods:Patients was randomly assigned in (1:1) ratio after randomization to either of two groups (35 in each group), one group prescribed glimepiride(1mg) +metformin (500mg) twice daily half an hour before meals and other group vildagliptin(50mg)+ metformin(500mg) twice daily half an hour before meals. HbA1c, FBS, PPBS was repeated at the end of 3rd month.Results:The mean HbA1c levels at baseline (0 weeks) were 8.80 ±0.62and 8.99 ±0.37 in Group A and Group B respectively. Similarly, at 12 weeks mean HbA1c levels were 6.47±0.44 and 6.42±0.42 in Group A and Group B respectively. The change in percentage of HbA1c at 12 weeks was -26.06% and -27.86% in Group A and Group B respectively but no statistical significance different was found. (P=0.26). The HbA1c levels < 7 were achieved among 29 (41.43%) subjects in Group A as compared to 28 (40%) subjects in Group B.The difference between HbA1c levels among study groups was not statistically significant. (P=0.75).Conclusion:The efficacy and tolerability of vildagliptin, was similar, with no significant differences, when used to treat type 2 diabetic patients with inadequate blood glucose control by dual combination of metformin and glimepiride.

Authors and Affiliations

P KalaiSelvi, D Nishanthini

Keywords

Related Articles

Patterns of prescription in a psychiatry out-patient department in a tertiary teaching hospital

Background: There is constantly increasing prevalence of psychiatric morbidity in Jammu and Kashmir State. Study of prescription pattern helps us to monitor, evaluate and if necessary suggest modifications in prescribing...

Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study

Background:Metformin and Vildagliptin have independent glucose-lowering properties and may increase GLP-1 levels by working through complementary mechanisms. The combination of metformin and glimepiride is a well-establi...

Effect of ciprofloxacin: A fluoroquinolone drug on psychomotor performance tests and blood sugar level in healthy humans

Background: Fluoroquinolones are widely used for infections butcan affect psychomotor function. Ciprofloxacin is known to cause anxiety, impairment of concentration, abnormal vision. Previous studies indicated a relation...

The efficacy and adverse effect profile of lithium versus Divalproex sodium in the treatment of patients with bipolar affective disorders on combination therapy - A comparative, naturalistic, clinical study

Objective: To compare the efficacy of Lithium versus Divalproex sodium in the treatment of patients with bipolar affective disorder on combination therapy. Methods: A prospective, comparative study was done comparing the...

Comparison of effects of metformin with combination of glimepride and metformin in type 2 diabetes patients

Background: The use of a fixed-dose combination pill of sulfonylurea and metformin has recently increased. Using a fixed-dose combination pill can improve patient compliance. Aim: To compare the effects of tformin with c...

Download PDF file
  • EP ID EP615747
  • DOI 10.26611/10101022
  • Views 121
  • Downloads 0

How To Cite

P KalaiSelvi, D Nishanthini (2019). Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study. Medpulse International Journal of Pharmacology, 10(2), 14-18. https://europub.co.uk/articles/-A-615747